RPRX Royalty Pharma plc
Healthcare$54.03+0.00%OpenMarket Cap: $23.24B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$53.75
Target (Median)
$53.50
Target Range
$45.00 - $63.00
Upside from current price: -0.5%
Rating Distribution
3 Strong Buy6 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-07 | Citigroup | maintain | Buy | Buy |
| 2026-04-21 | UBS | maintain | Buy | Buy |
| 2026-04-10 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-01-30 | UBS | upgrade | Buy | Neutral |
| 2026-01-27 | Citigroup | maintain | Buy | Buy |
| 2025-12-11 | TD Cowen | maintain | Buy | Buy |
| 2025-10-10 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-07-22 | Citigroup | maintain | Buy | Buy |
| 2025-07-10 | Morgan Stanley | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $5.62 | $3.71B | 5 |
| Sun Dec 31 | $6.28 | $4.03B | 2 |
| Mon Dec 31 | $7.04 | $4.59B | 1 |
| Tue Dec 31 | $7.71 | $4.99B | 1 |